Drugmaker Pulls Third-Line PARP Inhibitor Approval in Ovarian Cancer
Clovis Oncology has voluntarily withdrawn the indication for rucaparib (Rubraca) as a third-line treatment in BRCA-mutated ovarian cancer after an overall survival (OS) analysis showed a signal for potential harm, according to a filing with the Securities and Exchange Commission (SEC). “Based on further discussions with the FDA following submission of ARIEL4 OS data previously […]
Hair Care Product Recall Due to Benzene – MedicineNet Health News
Latest Prevention & Wellness News TUESDAY, Dec. 21, 2021 – Proctor & Gamble has voluntarily recalled several dry shampoo sprays and hair conditioner spray products with brand names Pantene, Herbal Essences, Aussie and Waterless because of benzene contamination. This follows an earlier recall of some aerosol spray Old Spice and Secret products, also […]